Related Experiment Video
Updated: Jan 14, 2026

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
Published on: June 12, 2021
CRATER tumor niches facilitate CD8+ T cell engagement and correspond with immunotherapy success
Aya Ludin1, Georgia L Stirtz2, Asaf Tal2
1Harvard Stem Cell and Regenerative Biology Department, Harvard University, Cambridge, MA 02138, USA; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA.
Abstract:
T cell-mediated tumor killing underlies immunotherapy success. Here, we used long-term in vivo imaging and high-resolution spatial transcriptomics of zebrafish endogenous melanoma, as well as multiplex imaging of human melanoma, to identify domains facilitating the immune response during immunotherapy. We identified cancer regions of antigen presentation and T cell engagement and retention (CRATERs) as pockets at the stroma-melanocyte boundaries of zebrafish and human melanoma. CRATERs are rich in antigen-recognition molecules, harboring the highest density of CD8+ T cells in tumors. In zebrafish, CD8+ T cells formed prolonged interactions with melanoma cells within CRATERs, characteristic of antigen recognition. Following immunostimulatory treatment, CRATERs expanded, becoming the major sites of activated CD8+ T cell accumulation and tumor killing. In humans, elevation in CRATER density in biopsies following immune checkpoint blockade (ICB) therapy correlated with a clinical response to therapy. CRATERs are structures that show active tumor killing and may be useful as a diagnostic indicator for immunotherapy success.
Insights
Researchers discovered Cancer Regions of Antigen Presentation and T cell Engagement and Retention (CRATERs) in melanoma. These regions are crucial for T cell activity and tumor killing, showing promise as biomarkers for immunotherapy success.
Area of Science:
- Immunology
- Oncology
- Spatial Biology
Background:
- T cell-mediated tumor killing is fundamental to immunotherapy efficacy.
- Understanding the spatial organization of immune cells within tumors is critical for optimizing cancer treatments.
Purpose of the Study:
- To identify specific microenvironmental domains that facilitate the immune response during cancer immunotherapy.
- To investigate the role of these domains in T cell engagement and tumor killing in melanoma.
Main Methods:
- Long-term in vivo imaging and high-resolution spatial transcriptomics in zebrafish melanoma models.
- Multiplex imaging of human melanoma biopsies.
- Analysis of T cell interactions and spatial distribution within tumor microenvironments.
Main Results:
- Identification of Cancer Regions of Antigen Presentation and T cell Engagement and Retention (CRATERs) at stroma-melanocyte boundaries in both zebrafish and human melanoma.
- CRATERs exhibit high density of CD8+ T cells and antigen-recognition molecules, facilitating prolonged T cell-melanoma cell interactions.
- CRATER expansion and density correlate with activated T cell accumulation, tumor killing, and clinical response to immunotherapy (including immune checkpoint blockade).
Conclusions:
- CRATERs represent key functional niches for T cell-mediated tumor killing during immunotherapy.
- The density and characteristics of CRATERs may serve as a predictive biomarker for immunotherapy response in melanoma patients.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
The Tumor Microenvironment
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...

